Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis

Hongyan Wang; Xuehan Gao; Xiaolin Zhang; Wenjian Gong; Ziheng Peng; Bingshuang Wang; Li Wang; Saishuo Chang; Peiru Ma; Shijie Wang

doi:10.12659/MSM.912373

20 October 2018 : Meta-Analysis

Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis

Hongyan Wang^1A, Xuehan Gao^2A, Xiaolin Zhang^3F, Wenjian Gong^2F, Ziheng Peng^2C, Bingshuang Wang^4B, Li Wang^2CD, Saishuo Chang^2D, Peiru Ma^2F, Shijie Wang^5A*

DOI: 10.12659/MSM.912373

Med Sci Monit 2018; 24: MTA7482-7492

Authors information Article notes Copyright and License information

Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy